Literature DB >> 3324941

Purification and biochemical properties of Pitton's type 2 beta-lactamase (SHV-1).

M Barthélémy1, J Peduzzi, C Verchère-Beaur, H Ben Yaghlane, R Labia.   

Abstract

A five-step procedure has been developed for purifying Pitton's type 2 plasmid-mediated beta-lactamase (PIT-2, also called SHV-1) from cultures of a hyperproducing variant of an Escherichia coli K12 strain carrying the plasmid p453. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis revealed a single protein band with a molecular weight of about 27,500. The amino acid composition of the protein and the amino acid sequence of the NH2-terminal region have been determined. PIT-2 enzyme contains 272 amino acid residues with 2 cysteines. Studies of the S-carboxymethylated protein (previously reduced or unreduced) suggest that these two residues are presumably in the form of free sulphydryl groups in the native protein. Conversely, TEM-2 beta-lactamase contains 2 cysteine residues which are in the form of a disulphide bond. Comparison of PIT-2 with other beta-lactamases was made using the difference index (DI) of Metzger et al. The PIT-2 enzyme appeared more closely related to the TEM-type penicillinases (DI of 6.5).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3324941     DOI: 10.1016/s0769-2609(86)80090-4

Source DB:  PubMed          Journal:  Ann Inst Pasteur Microbiol (1985)


  10 in total

1.  Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase.

Authors:  J Mercier; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

2.  Susceptibility of new beta-lactams to the expanded-spectrum beta-lactamase CTX-1.

Authors:  D Sirot; C Chanal; R Labia; J Sirot
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

Review 3.  Beta-lactamase nomenclature.

Authors:  George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France.

Authors:  M J Soilleux; A M Morand; G J Arlet; M R Scavizzi; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

5.  Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.

Authors:  C M Chanal; D L Sirot; R Labia; A Petit; A Morand; J L Sirot; R A Cluzel
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

6.  Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamase.

Authors:  J Péduzzi; M Barthélémy; K Tiwari; D Mattioni; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

7.  Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase (SHV-1).

Authors:  M Barthélémy; J Peduzzi; R Labia
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

8.  Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.

Authors:  A Petit; D L Sirot; C M Chanal; J L Sirot; R Labia; G Gerbaud; R A Cluzel
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

9.  Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.

Authors:  P Nordmann; E Ronco; T Naas; C Duport; Y Michel-Briand; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 10.  Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance.

Authors:  Teiji Sawa; Kunihiko Kooguchi; Kiyoshi Moriyama
Journal:  J Intensive Care       Date:  2020-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.